# A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks

> **NCT00427401** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 40 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** PF-00915275

## Key facts

- **NCT ID:** NCT00427401
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 40 (—)
- **Why stopped:** This study was terminated May 7, 2007. The study stopped due to tablet formulation issues. No safety issues were involved in the termination decision.
- **Last updated:** 2008-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427401, "A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00427401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*